Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	56,020	65,523	52,955	87,364	100,392	117,712
Market Cap Growth	-23.54%	23.73%	-39.39%	-12.98%	-14.71%	-17.59%
Enterprise Value	84,072	98,063	83,746	102,863	93,513	100,409
Last Close Price	3655.00	4275.00	3397.16	5483.79	6160.30	7081.66
PE Ratio	-	-	-	28.54	12.50	23.88
PS Ratio	0.28	0.33	0.28	0.47	0.60	0.84
PB Ratio	0.72	0.84	0.67	0.98	1.13	1.45
P/TBV Ratio	0.81	0.94	0.73	1.07	1.23	1.53
P/FCF Ratio	8.14	9.52	-	-	-	31.82
P/OCF Ratio	5.61	6.56	-	12.22	20.76	13.13
EV/Sales Ratio	0.42	0.49	0.44	0.55	0.56	0.72
EV/EBITDA Ratio	14.20	16.56	57.52	13.11	7.21	13.57
EV/EBIT Ratio	84.99	99.13	-	33.48	9.48	20.94
EV/FCF Ratio	12.21	14.25	-	-	-	27.14
Debt / Equity Ratio	0.63	0.63	0.63	0.52	0.35	0.16
Debt / EBITDA Ratio	8.28	8.28	34.65	5.90	2.40	1.70
Debt / FCF Ratio	7.13	7.13	-	-	-	3.41
Net Debt / Equity Ratio	0.36	0.36	0.39	0.17	-0.01	-0.20
Net Debt / EBITDA Ratio	4.74	4.74	21.47	1.98	-0.08	-2.18
Net Debt / FCF Ratio	4.08	4.08	-2.59	-0.95	0.08	-4.36
Asset Turnover	1.17	1.17	1.10	1.15	1.22	1.21
Inventory Turnover	2.96	2.96	3.05	2.84	2.58	2.72
Quick Ratio	0.66	0.66	0.66	0.76	0.91	1.43
Current Ratio	1.12	1.12	1.14	1.19	1.43	2.04
Return on Equity (ROE)	-0.77%	-0.77%	-6.35%	3.45%	9.47%	6.21%
Return on Assets (ROA)	0.36%	0.36%	-1.86%	1.17%	4.49%	2.59%
Return on Invested Capital (ROIC)	0.91%	0.91%	-4.79%	2.82%	12.39%	6.35%
Return on Capital Employed (ROCE)	1.00%	1.00%	-5.30%	3.00%	10.20%	5.50%
Earnings Yield	-1.08%	-0.92%	-10.12%	3.50%	8.00%	4.19%
FCF Yield	12.29%	10.51%	-22.82%	-18.58%	-14.08%	3.14%
Payout Ratio	-	-	-	63.76%	13.08%	19.43%
Buyback Yield / Dilution	-0.83%	-0.83%	10.92%	-11.57%	-0.18%	0.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.